5 results
8-K
EX-99.1
ADVM
Adverum Biotechnologies Inc
8 Feb 24
Regulation FD Disclosure
8:45am
Asian 27 (90%) 2 (7%) 28 (93%) 2 (7%) 55 (92%) 4 (7%) 30 (100%) 0 Mean years since nAMD diagnosis in the study eye (SD) 2.9 (2.8) 2.8 (3.1) 2.8 (2.9
PRE 14A
ADVM
Adverum Biotechnologies Inc
14 Apr 23
Preliminary proxy
6:03am
American or Black
Asian
White
LGBTQ+
Did Not Disclose Demographic Background
General
Our Board is divided into three classes. Each class has a three-year
- Prev
- 1
- Next